Article abstract


Nature Medicine 13, 1185 - 1192 (2007)
Published online: 16 September 2007 | doi:10.1038/nm1641

27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen

Michihisa Umetani1, Hideharu Domoto1, Andrew K Gormley2, Ivan S Yuhanna2, Carolyn L Cummins1, Norman B Javitt3, Kenneth S Korach4, Philip W Shaul2 & David J Mangelsdorf1


The cardioprotective effects of estrogen are mediated by receptors expressed in vascular cells. Here we show that 27-hydroxycholesterol (27HC), an abundant cholesterol metabolite that is elevated with hypercholesterolemia and found in atherosclerotic lesions, is a competitive antagonist of estrogen receptor action in the vasculature. 27HC inhibited both the transcription-mediated and the non-transcription-mediated estrogen-dependent production of nitric oxide by vascular cells, resulting in reduced estrogen-induced vasorelaxation of rat aorta. Furthermore, increasing 27HC levels in mice by diet-induced hypercholesterolemia, pharmacologic administration or genetic manipulation (by knocking out the gene encoding the catabolic enzyme CYP7B1) decreased estrogen-dependent expression of vascular nitric oxide synthase and repressed carotid artery reendothelialization. As well as antiestrogenic effects, there were proestrogenic actions of 27HC that were cell-type specific, indicating that 27HC functions as an endogenous selective estrogen receptor modulator (SERM). Taken together, these studies point to 27HC as a contributing factor in the loss of estrogen protection from vascular disease.

Top
  1. Department of Pharmacology and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, Texas 75390-9050, USA.
  2. Department of Pediatrics, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, Texas 75390-9050, USA.
  3. Department of Pediatrics and Medicine, New York University School of Medicine, New York, New York 10016, USA.
  4. Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, PO Box 12233, 111 Alexander Drive, Research Triangle Park, North Carolina 27709, USA.

Correspondence to: David J Mangelsdorf1 e-mail: davo.mango@utsouthwestern.edu



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

In vivo imaging reveals estrogen receptor's hidden personality

Nature Medicine News and Views (01 Jan 2003)

A new feature on the cholesterol-lowering landscape

Nature Medicine News and Views (01 Dec 2001)


Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

  • Protect Enzyme from In Planta Degradation

    • Deadline: Jul 15 2009
    • Reward: $20,000 USD

    A proposal for stable expression of an enzyme in corn seed is desired.

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

naturejobs

natureproducts


ADVERTISEMENT